​

Acrivon Therapeutics Ownership | Who Owns Acrivon Therapeutics?

OverviewForecastFinancialsChart

Acrivon Therapeutics Ownership Summary

Acrivon Therapeutics is owned by 61.01% institutional investors, 22.06% insiders, and 16.92% retail investors. Corton capital is the largest institutional shareholder, holding 0% of ACRV shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 1.82% of its assets in Acrivon Therapeutics shares.

ACRV Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAcrivon Therapeutics61.01%22.06%16.92%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Corton capital---
Russell investments group---
Pale fire capital se---
Trexquant investment lp---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Corton capital---
Russell investments group---
Pale fire capital se---
Trexquant investment lp---

Top Buyers

HolderShares% AssetsChange
Russell investments group---223.00
Corton capital---12.16K
Pale fire capital se---15.23K
Trexquant investment lp---16.87K

Top Sellers

HolderShares% AssetsChange
Trexquant investment lp---16.87K
Pale fire capital se---15.23K
Corton capital---12.16K
Russell investments group---223.00

Sold Out

HolderChange
Russell investments group-223.00
Corton capital-12.16K
Pale fire capital se-15.23K
Trexquant investment lp-16.87K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20245915.69%23,249,5511.26%611.68%3129.17%14-
Sep 30, 202451-22,960,755-2.09%601.43%24-31.43%14133.33%
Jun 30, 20245110.87%23,451,87853.83%641.43%3545.83%6-33.33%
Mar 31, 20244612.20%15,245,531-0.33%671.44%2433.33%9-
Dec 31, 202341-4.65%15,295,8761.34%681.47%18-5.26%9-25.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
HBM Healthcare Investments AG Ord566.65K1.82%-
Vanguard Total Stock Mkt Idx Inv412.43K1.32%2.97K
Vanguard US Total Market Shares ETF387.41K1.24%-
iShares Russell 2000 ETF268.18K0.86%45.00
Vanguard Institutional Extnd Mkt Idx Tr176.37K0.56%-
iShares Biotechnology ETF138.33K0.44%316.00
Fidelity Small Cap Index116.96K0.37%-
iShares Russell 2000 Value ETF112.94K0.36%-385.00
A4Investments SICAV SIF ACCI IlanaA2EURH84.78K0.27%30.72K
Fidelity Extended Market Index75.31K0.24%979.00

Recent Insider Transactions

DateNameRoleActivityValue
May 01, 2025PERCEPTIVE ADVISORS LLC-Sell$400.51K
Apr 30, 2025PERCEPTIVE ADVISORS LLC-Sell$617.41K
Apr 29, 2025PERCEPTIVE ADVISORS LLC-Sell$352.50K
Apr 25, 2025PERCEPTIVE ADVISORS LLC-Sell$2.06M
Apr 28, 2025PERCEPTIVE ADVISORS LLC-Sell$335.84K

Insider Transactions Trends

DateBuySell
2025 Q2-5
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q21-

ACRV Ownership FAQ

Who Owns Acrivon Therapeutics?

Acrivon Therapeutics shareholders are primarily institutional investors at 61.01%, followed by 22.06% insiders and 16.93% retail investors. The average institutional ownership in Acrivon Therapeutics's industry, Biotech Stocks , is 68.48%, which Acrivon Therapeutics falls below.

Who owns the most shares of Acrivon Therapeutics?

Acrivon Therapeutics’s largest shareholders are Corton capital (0 shares, 0%), Russell investments group (0 shares, 0%), and Pale fire capital se (0 shares, 0%). Together, they hold 0% of Acrivon Therapeutics’s total shares outstanding.

Does Blackrock own Acrivon Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Acrivon Therapeutics.

Who is Acrivon Therapeutics’s biggest shareholder by percentage of total assets invested?

Corton capital is Acrivon Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Acrivon Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Acrivon Therapeutics shares?

HBM Healthcare Investments AG Ord is the top mutual fund holder of Acrivon Therapeutics shares, with 1.82% of its total shares outstanding invested in 566.65K Acrivon Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools